Table 3.
Logistic regression analyses on patients with low GalNAC-T3 expression and clinical pathologic characteristics
| Variable | Odds ratio | 95% CI | P-value |
|---|---|---|---|
| IASLC/ATS/ERS classification risk group | |||
| High risk grade | 1 | ||
| Moderate risk grade | 0.122 | 0.017–0.871 | 0.018 |
| Low risk grade | 0.141 | 0.027–0.719 | 0.036 |
| Sica score | |||
| 0 or 2 or 3 | 1 | ||
| 4 | 0.286 | 0.016–4.981 | 0.391 |
| 5 or 6 | 0.227 | 0.011–5.597 | 0.334 |
| Differentiation | |||
| Poor | 1 | ||
| Moderate | 1.407 | 0.182–10.891 | 0.744 |
| Well | 0.699 | 0.093–5.266 | 0.010 |
| Pleural invasion | |||
| Absent | 1 | ||
| Present | 172.128 | 0.012–1,291.175 | 0.94 |
| Vascular invasion | |||
| Absent | 1 | ||
| Present | 5.668 | 1.827–17.578 | 0.003 |
| TNM stages | |||
| Stage I and 0 | 1 | ||
| Stage II and III | 8.957 | 1.797–44.661 | 0.007 |
Abbreviations: IASLC, International Association for the Study of Lung Cancer; ATS, the American Thoracic Society; ERS, European Respiratory Society; CI, confidence interval; TNM, tumor-node-metastasis.